Applications

Encapsulation

Monodisperse microcapsules with CV < 5% and a defined size from 1 to 1000 µm — on one platform, with a single chip change.

Encapsulation
CV < 5%
capsule monodispersity
1–1000 µm
capsule size range
0.1 µl/min – 10 ml/min
workstation flow-rate range
Problem

Mechanical stirring and homogenization produce polydisperse capsules with a wide size distribution. The result is inconsistent dosing, unpredictable release kinetics and poor batch-to-batch reproducibility. For premium cosmetics, controlled-release pharma and precision agriculture, that level of polydispersity is unacceptable.

Solution

Microfluidic droplet generation forms monodisperse microcapsules with CV < 5%: every capsule is the same size, with the same payload and the same release rate. Size is set across the 1–1000 µm range via phase flow rates and chip geometry, with no re-tuning between batches. Low shear forces preserve sensitive payloads — live cells, enzymes and fragile molecules. The same workstation used for flow chemistry and LNP formulation moves to encapsulation with a chip change.

Result

Encapsulation is established and validated in a project with a global FMCG company: vitamin encapsulation and cosmetics testing. We tailor core-shell, double-emulsion and multi-compartment chip geometries to your payload, target size and release kinetics, delivered with a reproducible protocol.

Capabilities

What you can do.

Droplet generation and monodispersity with CV < 5 % at a target size of 1–1000 µm
Core-shell structures, double emulsions and multi-compartment capsules with shell-thickness control
Low-shear processing to preserve living cells, enzymes and fragile molecules
Selection of chip geometry and phase flow rates to match target size and release kinetics
Applications: cosmetics, controlled-release pharma, agriculture and food technology
A reproducible protocol and a switch to encapsulation by changing the chip — without a new setup
Interested in microfluidic technology?

Book a meeting with our team